Medical Xpress news

Medical Xpress / Reversing immune suppression in pancreatic cancer could lead to novel therapies

In a unique finding, researchers at Georgetown's Lombardi Comprehensive Cancer Center discovered that when pancreatic cancer cells send out tiny particles that are packed with certain microRNA molecules, nearby immune cells ...

Jan 16, 2026 in Oncology & Cancer
Medical Xpress / Decline in U.S. nursing home capacity since COVID-19: Rural areas hit hardest

Though the U.S. population is aging, nursing home capacity has declined nationwide since the COVID-19 pandemic began. According to a study published in JAMA Internal Medicine this week, one quarter of U.S. counties experienced ...

Jan 16, 2026 in Medical economics
Medical Xpress / Dual therapy shows promise for childhood brain cancer

Researchers at the Children's Cancer Institute and UNSW Sydney have tested a new way of treating childhood brain cancer by combining two medicines in lab studies. They found using the two treatments together may work better ...

Jan 16, 2026 in Oncology & Cancer
Medical Xpress / Research reveals clues as to why standard antidepressants fail for so many

A study from the University of Sydney's Brain and Mind Center reveals new clues as to why standard antidepressants fail for many Australians, opening the door for more effective, personalized treatments.

Jan 16, 2026 in Medications
Medical Xpress / Asthma-related depression may be biologically distinct from primary depression

Researchers from Hiroshima University in Japan and collaborating institutions have found that adults with asthma who experience symptoms of depression have elevated blood levels of a protein called brain-derived neurotrophic ...

Jan 16, 2026 in Psychology & Psychiatry
Medical Xpress / Simulations predict antibody drug viscosity, paving way for easier self-injection

Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick up the medicine every few weeks. It would be easier for them to be able to inject the medicine themselves ...

Jan 16, 2026 in Medications
Medical Xpress / What a study of 67,000 people reveals about sexual desire and age

Sexual desire is a fundamental part of being human and a driving force in many relationships, yet we still don't fully understand why it varies so much from person to person.

Jan 15, 2026 in Psychology & Psychiatry
Medical Xpress / Altered microbiome: Oral bacteria play a role in chronic liver disease, study reveals

Each year, more than two million people die from advanced chronic liver disease (ACLD). Previous research has linked gut microbiome disruptions to this condition and suggested that bacteria typically found in the mouth may ...

Medical Xpress / Parenthood 'inoculates' adults against disgust, new study reveals

From diaper changes to nursing care, exposure to unpleasant substances is a daily reality for millions of people, but how does the brain adapt? New research from neuroscientists at the University of Bristol reveals that repeated, ...

Jan 15, 2026 in Psychology & Psychiatry
Medical Xpress / From yoga to awe walks: Many paths lead to better mental health, largest analysis of well-being interventions finds

As another new year gets under way, many of us will be looking for a way of boosting how we feel, but is it better to hit the gym or meditate in nature? Now new research by Swansea experts has provided the largest ever comparison ...

Jan 15, 2026 in Psychology & Psychiatry
Medical Xpress / Sudden cardiac arrest in athletes: Hidden heart conditions can trigger rare but fatal events during competition

Though rare, sudden cardiac arrest (SCA) in athletes often unfolds in high-visibility settings, like sports arenas, prompting questions about underlying causes, emergency preparedness, and long-term outcomes. A new review ...

Jan 15, 2026 in Cardiology
Medical Xpress / New ALS treatment target identified: STAUFEN-1 protein reduction protects brain cells from death

University of Utah researchers at the Pulst-Scoles Laboratory have discovered that reducing levels of the STAUFEN-1 protein can prevent neuron death caused by DNA damage and p53 activation in neurodegenerative diseases.